Skip to content

Ingevity NGVT Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Cabot Corporation logo
Cabot CorporationCBT
$6M+20.0%
Sherwin-Williams logo
Sherwin-WilliamsSHW
$47.6M+81.7%
Chemours logo
ChemoursCC
$2M
Innospec logo
InnospecIOSP
$100K-50.0%
Minerals Technologies logo
Minerals TechnologiesMTX
$1M+900%
Entegris logo
EntegrisENTG
$14.3M+921%

Other financials

Income statement

See full
Revenue$258.0M+4.1%
Gross profit$116.4M+4.0%
Net income$59.8M+192%
EPS (diluted)$1.66+196%

Balance sheet

See full
Cash & equivalents$95.4M+5.0%
Total debt$1.4B-9.0%
Total equity$38.9M-83.4%
Total assets$1.7B-19.7%

Cash flow

See full
Operating cash flow-$2.0M-108%
CapEx$10.3M+3.0%
Free cash flow-$12.3M-180%

Valuation

See full
Market cap$2.53B+73.9%
Enterprise value$3.8B+32.4%
P/S2.1×+0.9×

Profitability

See full
Gross margin39.3%+1.5pp
Net margin-10.6%-4.1pp
FCF margin20.3%+12.6pp

Returns & leverage

See full
Return on equity-93.5%+1.2pp
Debt / equity35.1×+28.7×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Ingevity in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Ingevity’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingevity's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ingevity's stock issuance proceeds?
Ingevity (NGVT) reported stock issuance proceeds of $3.3M in Q1 2026.
What is the long-term trend for Ingevity's stock issuance proceeds?
Over 3 years (2021 to 2024), Ingevity's stock issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $4.7M to $0.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.